On June 17, 2022, the U.S. Food and Drug Administration (FDA) granted emergency authorization (EUA) for the Moderna and Pfizer/BioNTech CCP virus vaccines to be administered to infants as young as 6 months old.
Previously, on June 15, the FDA’s committee of independent vaccine experts voted unanimously to endorse CCP virus vaccines for use in youngest children; although, the CDC must still give its approval before those children can start receiving their vaccination, which could happen as early as this week.
The FDA says that Pfizer’s vaccines had previously been approved for use in children at least 5 years old, while the Moderna vaccine had only been approved for use in people ages 18 and up.
According to the reports, after the FDA’s authorization on June 17, the Moderna vaccines will be administered in two or three shots with one month in between each; with the Pfizer vaccine, all kids ages 6 months through 4 years will get three shots, the first two of the three weeks apart, followed by a third dose at least eight weeks later.
Pfizer also explained that the version of the injections that will be administered to children this young is different from the original adult vials, which is Pfizer’s case contain 10 times more “solution” than the baby version.
The White House has said that the vaccinations could start as early as June 21, though vaccine availability could vary from state to state.